KDM5A and breast carcinoma: A previous study reported that PI3K/Akt signaling regulates the H3K4me3 mark through KDM5A phosphorylation in breast cancer.18 Phospho‐Akt can prevent nuclear localization of KDM5A by inducing phosphorylation of KDM5A.